Lasa Supergenerics Limited (NSE:LASA)
India · Delayed Price · Currency is INR 6.52
-0.17 (-2.54%)
Sep 9, 2026, 3:31 PM IST
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 326.66 million as of September 11, 2026. Its market cap has decreased by -38.78% in one year.
Market Cap
326.66M
Enterprise Value
417.17M
Revenue
65.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.52
ChartMarket Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 326.66M, a decrease of -90.76%. That is a compound annual growth rate of -23.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 326.66M | -30.93% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anlon Healthcare | 9.32B |
| Amanta Healthcare | 7.83B |
| Bafna Pharmaceuticals | 7.28B |
| Valiant Laboratories | 6.78B |
| Nectar Lifesciences | 2.32B |
| Brooks Laboratories | 1.88B |
| Par Drugs and Chemicals | 1.74B |
| Alpa Laboratories | 1.32B |